Deutsche Bank’s MacroGenics MGNX Stock Holding History

Deutsche Bank’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-51,093	Closed	-$64.9K	–	3678
2025 Q1	$64.9K	Buy	51,093 +49,784	+3,803%	+$130K	﹤0.01%	3317
2024 Q4	$4.25K	Sell	1,309 -42,546	-97%	-$153K	﹤0.01%	3544
2024 Q3	$144K	Buy	43,855 +10,291	+31%	+$40.1K	﹤0.01%	3082
2024 Q2	$143K	Sell	33,564 -5,836	-15%	-$56.8K	﹤0.01%	2987
2024 Q1	$580K	Sell	39,400 -148,932	-79%	-$2.25M	﹤0.01%	2280
2023 Q4	$1.81M	Buy	188,332 +163,177	+649%	+$1.13M	﹤0.01%	1727
2023 Q3	$117K	Sell	25,155 -157,079	-86%	-$782K	﹤0.01%	3084
2023 Q2	$975K	Sell	182,234 -16,645	-8%	-$103K	﹤0.01%	2004
2023 Q1	$1.43M	Buy	198,879 +11,816	+6%	+$71.2K	﹤0.01%	1883
2022 Q4	$1.26M	Buy	187,063 +162,304	+656%	+$890K	﹤0.01%	1904
2022 Q3	$86K	Sell	24,759 -238,842	-91%	-$914K	﹤0.01%	3399
2022 Q2	$778K	Buy	263,601 +226,157	+604%	+$1.19M	﹤0.01%	2331
2022 Q1	$330K	Sell	37,444 -3,802	-9%	-$42K	﹤0.01%	2992
2021 Q4	$662K	Buy	41,246 +1,807	+5%	+$34K	﹤0.01%	2663
2021 Q3	$826K	Sell	39,439 -486	-1%	-$11.7K	﹤0.01%	2737
2021 Q2	$1.07M	Buy	39,925 +2,668	+7%	+$78.1K	﹤0.01%	2722
2021 Q1	$1.19M	Sell	37,257 -2,006	-5%	-$48.7K	﹤0.01%	2555
2020 Q4	$897K	Buy	39,263 +9,429	+32%	+$217K	﹤0.01%	2524
2020 Q3	$752K	Sell	29,834 -45,599	-60%	-$1.25M	﹤0.01%	2379
2020 Q2	$2.11M	Sell	75,433 -121,431	-62%	-$2.11M	﹤0.01%	1757
2020 Q1	$1.15M	Sell	196,864 -33,287	-14%	-$302K	﹤0.01%	2007
2019 Q4	$2.5M	Buy	230,151 +79,972	+53%	+$792K	﹤0.01%	1832
2019 Q3	$1.92M	Buy	150,179 +56,642	+61%	+$816K	﹤0.01%	1944
2019 Q2	$1.58M	Sell	93,537 -161,955	-63%	-$2.78M	﹤0.01%	2549
2019 Q1	$4.59M	Buy	255,492 +240,746	+1,633%	+$4.16M	﹤0.01%	1924
2018 Q4	$185K	Sell	14,746 -113,989	-89%	-$1.91M	﹤0.01%	3917
2018 Q3	$2.76M	Buy	128,735 +13,437	+12%	+$286K	﹤0.01%	2638
2018 Q2	$2.38M	Sell	115,298 -108,626	-49%	-$2.45M	﹤0.01%	2837
2018 Q1	$5.63M	Buy	223,924 +2,072	+0.9%	+$50.3K	﹤0.01%	2114
2017 Q4	$4.21M	Buy	221,852 +100,834	+83%	+$1.88M	﹤0.01%	2154
2017 Q3	$2.23M	Sell	121,018 -41,559	-26%	-$720K	﹤0.01%	2465
2017 Q2	$2.85M	Buy	162,577 +116,435	+252%	+$2.22M	﹤0.01%	2330
2017 Q1	$856K	Buy	46,142 +26,775	+138%	+$517K	﹤0.01%	2757
2016 Q4	$394K	Sell	19,367 -11,201	-37%	-$282K	﹤0.01%	3316
2016 Q3	$913K	Sell	30,568 -28,681	-48%	-$853K	﹤0.01%	2878
2016 Q2	$1.6M	Buy	59,249 +51,966	+714%	+$1.17M	﹤0.01%	2561
2016 Q1	$136K	Sell	7,283 -11,523	-61%	-$219K	﹤0.01%	3841
2015 Q4	$581K	Sell	18,806 -18,048	-49%	-$548K	﹤0.01%	3199
2015 Q3	$789K	Buy	36,854 +25,996	+239%	+$815K	﹤0.01%	3097
2015 Q2	$411K	Buy	10,858 +2,866	+36%	+$94.2K	﹤0.01%	3510
2015 Q1	$249K	Sell	7,992 -3,223	-29%	-$109K	﹤0.01%	3683
2014 Q4	$392K	Buy	11,215 +2,706	+32%	+$67.5K	﹤0.01%	3840
2014 Q3	$176K	Sell	8,509 -11,693	-58%	-$242K	﹤0.01%	4153
2014 Q2	$438K	Buy	20,202 +3,379	+20%	+$71K	﹤0.01%	3565
2014 Q1	$467K	Sell	16,823 -4,924	-23%	-$174K	﹤0.01%	3387
2013 Q4	$596K	Buy	+21,747	New	+$569K	﹤0.01%	2982

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank's MGNX Position: Q2 2025 in Review

Deutsche Bank sold out of MacroGenics (MGNX) in Q2 2025, closing a stake of 51,093 shares — an estimated $64.9K sold.

Deutsche Bank first reported a position in MGNX in Q4 2013 and held it in 46 quarters. The position peaked at $5.63M in Q1 2018. 112 funds tracked by Wall St. Rank hold MGNX as of Q2 2025.

Deutsche Bank reported no remaining MacroGenics position as of Q2 2025 after selling out during the quarter.
Deutsche Bank sold 51,093 MacroGenics shares in Q2 2025, an estimated $64.9K.
Deutsche Bank first reported a position in MacroGenics in Q4 2013 and held it in 46 quarters.
Deutsche Bank's MacroGenics position peaked at $5.63M in Q1 2018.
112 funds tracked by Wall St. Rank held MacroGenics as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.